Seer (SEER) Current Assets (2020 - 2026)
Seer (SEER) recorded quarterly Current Assets of $181.6 million in Q1 2026, down 9.89% quarter-over-quarter from $201.5 million in Q4 2025, and down 28.86% on a YoY basis from $255.3 million in Q1 2025.
Seer (SEER) Current Assets (2020 - 2026) Analysis & Trends
Seer's Current Assets history runs 7 years deep, the most recent figure standing at $181.6 million for Q1 2026.
- In Q1 2026, Current Assets fell 28.86% year-over-year to $181.6 million; the TTM figure through Mar 2026 stood at $181.6 million (down 28.86% YoY), while the FY2025 annual figure was $201.5 million, down 20.44% from the prior year.
- Current Assets was $181.6 million for Q1 2026 at Seer, down from $201.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $466.8 million in Q2 2022 to a low of $181.6 million in Q1 2026.
- Historically, Current Assets has averaged $318.2 million across 5 years, with a median of $324.2 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Current Assets increased 5.66% in 2022, then fell 28.86% in 2026.
- A 5-year view of Current Assets shows it stood at $435.0 million in 2022, then retreated by 24.02% to $330.5 million in 2023, then decreased by 23.35% to $253.3 million in 2024, then slipped by 20.44% to $201.5 million in 2025, then retreated by 9.89% to $181.6 million in 2026.
- The last three Current Assets figures came in at $181.6 million (Q1 2026), $201.5 million (Q4 2025), and $214.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 600.85 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 181.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.59 Mn |
| Dec 31, 2025 | 201.53 Mn |
| Sep 30, 2025 | 214.36 Mn |
| Jun 30, 2025 | 225.64 Mn |
| Mar 31, 2025 | 255.27 Mn |
| Dec 31, 2024 | 253.32 Mn |
| Sep 30, 2024 | 264.10 Mn |
| Jun 30, 2024 | 299.69 Mn |
| Mar 31, 2024 | 324.15 Mn |
| Dec 31, 2023 | 330.51 Mn |
| Sep 30, 2023 | 346.12 Mn |
| Jun 30, 2023 | 335.38 Mn |
| Mar 31, 2023 | 367.38 Mn |
| Dec 31, 2022 | 434.98 Mn |
| Sep 30, 2022 | 450.47 Mn |
| Jun 30, 2022 | 466.76 Mn |
| Mar 31, 2022 | 457.46 Mn |
| Dec 31, 2021 | 411.70 Mn |
| Sep 30, 2021 | 514.27 Mn |
| Jun 30, 2021 | 525.33 Mn |